The systemic spread of seropositive RA-associated immune cells, autoantibodies (particularly ACPA), and inflammatory mediators via the bloodstream constitutes a crucial pathway that drives both the onset of immune dysregulation and the ongoing inflammation characteristic of seropositive RA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.